CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.

doi:10.1158/1055-9965.EPI-09-0496

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2009

Travis Ruth C, Schumacher Fredrick, Hirschhorn Joel N, Kraft Peter, Allen Naomi E, Albanes Demetrius, Berglund Goran, Berndt Sonja I, Boeing Heiner, Bueno-de-Mesquita H Bas, Calle Eugenia E, Chanock Stephen, Dunning Alison M, Hayes Richard, Feigelson Heather Spencer, Gaziano J Michael, Giovannucci Edward, Haiman Christopher A, Henderson Brian E, Kaaks Rudolf, Kolonel Laurence N, Ma Jing, Rodriguez Laudina, Riboli Elio, Stampfer Meir, Stram Daniel O, Thun Michael J, Tjønneland Anne, Trichopoulos Dimitrios, Vineis Paolo, Virtamo Jarmo, Le Marchand Loïc, Hunter David J

Abstract excerpt

Sex hormones, particularly the androgens, are important for the growth of the prostate gland and have been implicated in prostate cancer carcinogenesis, yet the determinants of endogenous steroid hormone levels remain poorly understood. Twin studies suggest a heritable component for circulating c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Aromatase

Share to Case-Control Studies

Share to Cohort Studies

Share to Disease Progression

Share to Gonadal Steroid Hormones

Share to Neoplasm Staging

Share to Prognosis

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 19789370
DOI: 10.1158/1055-9965.EPI-09-0496
PMCID: PMC2812905

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19789370-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.PMID 19789370Read ↗

Genetic variation in the HSD17B1 gene and risk of prostate cancer.Semantic proximity Read ↗

Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women.Semantic proximity Read ↗

CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).Semantic proximity Read ↗

Effects of functional genetic polymorphisms in the CYP19A1 gene on prostate cancer risk and survival.Semantic proximity Read ↗

A Large Study of Androgen Receptor Germline Variants and Their Relation to Sex Hormone Levels and Prostate Cancer Risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort ConsortiumSemantic proximity Read ↗

Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.Semantic proximity Read ↗

Identifying susceptibility genes for prostate cancer--a family-based association study of polymorphisms in CYP17, CYP19, CYP11A1, and LH-beta.Semantic proximity Read ↗

Variant in sex hormone-binding globulin gene and the risk of prostate cancer.Semantic proximity Read ↗

Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors.Semantic proximity Read ↗

Benign prostatic hyperplasia genetic variants in Asians.Semantic proximity Read ↗

Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.